Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations

The past decade has witnessed major strides in the prevention of coronary heart disease (CHD) through modification of its causes. The most dramatic advance has been the demonstration that aggressive medical therapy will substantially reduce the likelihood of recurrent major coronary syndromes in patients with established CHD (secondary prevention). The American Heart Association (AHA) and the American College of Cardiology (ACC) have published joint recommendations for medical intervention in patients with CHD and other forms of atherosclerotic disease.1 A similar potential exists for risk reduction in patients without established CHD (primary prevention). However, the risk status of persons without CHD varies greatly, and this variability mandates a range in the intensity of interventions. Effective primary prevention thus requires an assessment of risk to categorize patients for selection of appropriate interventions. The present statement is being published jointly by the AHA and ACC to outline current issues and approaches to global risk assessment for primary prevention. The approaches described in this statement can be used for guidance at several levels of primary prevention; however, the statement does not attempt to specifically link risk assessment to treatment guidelines for particular risk factors. Nonetheless, it provides critical background information that can be used in the development of new treatment guidelines. The major and independent risk factors for CHD are cigarette smoking of any amount, elevated blood pressure, elevated serum total cholesterol and low-density lipoprotein cholesterol (LDL-C), low serum high-density lipoprotein cholesterol (HDL-C), diabetes mellitus, and advancing age (Table 1⇓). The quantitative relationship between these risk factors and CHD risk has been elucidated by the Framingham Heart Study2 and other studies. These studies2 show that the major risk factors are additive in predictive power. Accordingly, the total risk of a person can be estimated by a summing of the risk …

[1]  P. Wilson,et al.  Diabetes mellitus and coronary heart disease. , 2001, Endocrinology and metabolism clinics of North America.

[2]  Teven,et al.  MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .

[3]  S. Grundy Primary prevention of coronary heart disease: integrating risk assessment with intervention. , 1999, Circulation.

[4]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[5]  R. Krauss,et al.  Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1999, Circulation.

[6]  B. Davis,et al.  Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. , 1998, Circulation.

[7]  R. Collins,et al.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.

[8]  G. Mancia,et al.  Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Atherosclerosis.

[9]  E. Giltay,et al.  Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[10]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[11]  A. Karter,et al.  Ischemic heart disease and stroke mortality in African-American, Hispanic, and non-Hispanic white men and women, 1985 to 1991. , 1998, The Western journal of medicine.

[12]  G. Montalescot,et al.  Fibrinogen as a risk factor for coronary heart disease. , 1998, European heart journal.

[13]  B. Horne,et al.  Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. , 1998, Journal of the American College of Cardiology.

[14]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[15]  S M Grundy,et al.  Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. , 1998, Circulation.

[16]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[17]  Grundy,et al.  Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue , 1998, Journal of internal medicine.

[18]  S. Grundy Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. , 1998, The American journal of cardiology.

[19]  J. Hokanson,et al.  Hypertriglyceridemia as a cardiovascular risk factor. , 1998, The American journal of cardiology.

[20]  E. Eaker Psychosocial risk factors for coronary heart disease in women. , 1998, Cardiology clinics.

[21]  M. A. White,et al.  Arabian Peninsula men tend to insulin resistance and cardiovascular risk seen in South Asians , 1998, Tropical medicine & international health : TM & IH.

[22]  S. Haffner Management of Dyslipidemia in Adults With Diabetes , 1998, Diabetes Care.

[23]  W. Roos,et al.  Development of a new microparticle‐enhanced turbidimetric assay for C‐reactive protein with superior features in analytical sensitivity and dynamic range , 1998, Journal of clinical laboratory analysis.

[24]  A. von Eckardstein,et al.  The emergence of triglycerides as a significant independent risk factor in coronary artery disease. , 1998, European heart journal.

[25]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .

[26]  B. Mozes,et al.  Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium. , 1998, The American journal of cardiology.

[27]  J. Gerich Metabolic abnormalities in impaired glucose tolerance. , 1997, Metabolism: clinical and experimental.

[28]  I. Ockene,et al.  Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. , 1997, Circulation.

[29]  R. Eckel,et al.  Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1997, Circulation.

[30]  K. King Psychologic and social aspects of cardiovascular disease , 1997, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[31]  G. Fletcher How to implement physical activity in primary and secondary prevention. A statement for healthcare-professionals from the Task Force on Risk-reduction, American Heart Association. , 1997, Circulation.

[32]  J. Witteman,et al.  Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.

[33]  H. Krumholz,et al.  Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee. , 1997, Circulation.

[34]  Terje R Pedersen,et al.  Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.

[35]  D. Labarthe,et al.  Greater incidence of hospitalized myocardial infarction among Mexican Americans than non-Hispanic whites. The Corpus Christi Heart Project, 1988-1992. , 1997, Circulation.

[36]  M. Evans,et al.  Body weight and mortality among women. , 1997, Canadian family physician Medecin de famille canadien.

[37]  Detection The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[38]  R M Peshock,et al.  Relationship of Generalized and Regional Adiposity to Insulin Sensitivity in Men With NIDDM , 1996, Diabetes.

[39]  D L Rothman,et al.  Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. , 1996, The New England journal of medicine.

[40]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[41]  R. Krauss,et al.  Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. , 1996, JAMA.

[42]  F. Mayet,et al.  Risk factors leading to coronary heart disease among the black, Indian and white peoples of Durban. , 1996, Journal of human hypertension.

[43]  P. Wilson,et al.  Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. , 1996, JAMA.

[44]  J. Després,et al.  The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men , 1996, Diabetes Care.

[45]  L. Kuller,et al.  Coronary artery disease in IDDM. Gender differences in risk factors but not risk. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[46]  K. Robinson,et al.  Homocysteine and coronary atherosclerosis. , 1996, Journal of the American College of Cardiology.

[47]  N. Rigotti,et al.  Cigarette smoking and coronary heart disease: risks and management. , 1996, Cardiology clinics.

[48]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[49]  J. Macintyre,et al.  Physical Fitness and All-Cause Mortality , 1995 .

[50]  V. Fuster,et al.  Preventing heart attack and death in patients with coronary disease. , 1995, Circulation.

[51]  E. Boerwinkle,et al.  No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[52]  W. Vermaak,et al.  Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. , 1995, Clinical chemistry.

[53]  D Spiegelman,et al.  Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. , 1995, American journal of epidemiology.

[54]  R S Paffenbarger,et al.  Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. , 1995, JAMA.

[55]  A. Lindgren,et al.  Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid , 1995, Journal of internal medicine.

[56]  T. Meade,et al.  Fibrinogen in ischaemic heart disease. , 1995, European heart journal.

[57]  R. Krauss,et al.  Dense low density lipoproteins and coronary artery disease. , 1995, The American journal of cardiology.

[58]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.

[59]  J. Staessen,et al.  Relation of left ventricular mass and filling to exercise blood pressure and rest blood pressure. , 1995, The American journal of cardiology.

[60]  M. Emond,et al.  Long‐term Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry , 1994, Circulation.

[61]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice , 1994 .

[62]  G. Dahlén Lp(a) lipoprotein in cardiovascular disease. , 1994, Atherosclerosis.

[63]  R. Bergman,et al.  Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[64]  J. Stengård,et al.  Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.

[65]  C. Burchfiel,et al.  Physical activity and 23-year incidence of coronary heart disease morbidity and mortality among middle-aged men. The Honolulu Heart Program. , 1994, Circulation.

[66]  M. Laakso,et al.  Isolated Low HDL Cholesterol: An Insulin-Resistant State , 1994, Diabetes.

[67]  D. Labarthe,et al.  Greater case-fatality after myocardial infarction among Mexican Americans and women than among non-Hispanic whites and men. The Corpus Christi Heart Project. , 1994, American journal of epidemiology.

[68]  S M Grundy,et al.  Excess body weight. An under-recognized contributor to dyslipidemia in white American women. , 1994, Archives of internal medicine.

[69]  M. Law,et al.  Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study , 1994, BMJ.

[70]  R. Bhopal,et al.  Coronary risk in a British Punjabi population: comparative profile of non-biochemical factors. , 1994, International journal of epidemiology.

[71]  C. Bouchard,et al.  Physical activity, fitness, and coronary heart disease. , 1994 .

[72]  L. Wilkins,et al.  National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994, Circulation.

[73]  P. Ridker,et al.  A prospective study of lipoprotein(a) and the risk of myocardial infarction. , 1993, JAMA.

[74]  Pi-Sunyer Fx Short-Term Medical Benefits and Adverse Effects of Weight Loss , 1993 .

[75]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[76]  S. Grundy,et al.  Excess body weight: An underrecognized contributor to high blood cholesterol levels in white American men , 1993 .

[77]  T. W. Smith,et al.  Cynical hostility and cardiovascular reactivity during self‐disclosure. , 1993, Psychosomatic medicine.

[78]  J S Yudkin,et al.  Impaired glucose tolerance. , 1990, BMJ.

[79]  I. Piña,et al.  Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart association. , 1992, Circulation.

[80]  P. Rust,et al.  Body mass index and body girths as predictors of mortality in black and white women. , 1992, Archives of internal medicine.

[81]  G. Reaven Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease. , 1991, American heart journal.

[82]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[83]  M. Austin Plasma triglyceride and coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[84]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.

[85]  W. Kannel,et al.  Parental history is an independent risk factor for coronary artery disease: the Framingham Study. , 1990, American heart journal.

[86]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[87]  S. Haffner,et al.  Overweight and mortality in Mexican Americans. , 1990, International journal of obesity.

[88]  R. Campbell,et al.  Coronary heart disease in high-risk populations: lessons from Finland. , 1990, European heart journal.

[89]  R S Paffenbarger,et al.  Physical fitness and all-cause mortality. A prospective study of healthy men and women. , 1989, JAMA.

[90]  A. Jaffe,et al.  The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. , 1989, Journal of the American College of Cardiology.

[91]  J. Huttunen,et al.  Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study. , 1989, The American journal of cardiology.

[92]  Ronald M. Lauer,et al.  National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health. , 1991, Archives of internal medicine.

[93]  A. Jaffe,et al.  The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. , 1989, Journal of the American College of Cardiology.

[94]  P. Wilson,et al.  Leisure time physical activity in the Framingham Offspring Study. Description, seasonal variation, and risk factor correlates. , 1989, American journal of epidemiology.

[95]  G. Rosenhamer,et al.  Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. , 2009, Acta medica Scandinavica.

[96]  G. Fraser,et al.  Determinants of ischemic heart disease in Seventh-day Adventists: a review. , 1988, The American journal of clinical nutrition.

[97]  L. Landsberg,et al.  Mechanisms in obesity-related hypertension: role of insulin and catecholamines. , 1988, American journal of hypertension.

[98]  T. Farag Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.

[99]  J. Neaton,et al.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.

[100]  R. D'Agostino,et al.  Physical activity and physical demand on the job and risk of cardiovascular disease and death: the Framingham Study. , 1986, American heart journal.

[101]  W. Castelli,et al.  The triglyceride issue: a view from Framingham. , 1986, American heart journal.

[102]  S. Blair,et al.  Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. , 1985, American heart journal.

[103]  H. Blackburn,et al.  The seven countries study: 2,289 deaths in 15 years. , 1984, Preventive medicine.

[104]  S. Lillioja,et al.  Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. , 1984, The Journal of clinical investigation.

[105]  I. Ringqvist,et al.  Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). , 1983, The Journal of clinical investigation.

[106]  I. Ringqvist,et al.  Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry , 1982, Circulation.

[107]  P. Bennett,et al.  Mortality as a function of obesity and diabetes mellitus. , 1982, American journal of epidemiology.

[108]  C. G. Blomqvist,et al.  Statement on exercise , 1982 .

[109]  E. Thaulow,et al.  Natural history of cornary artery disease studied by coronary arteriography. A seven-year study of 795 patients. , 1981, Acta medica Scandinavica.

[110]  W. Kannel,et al.  Some health benefits of physical activity. The Framingham Study. , 1979, Archives of internal medicine.

[111]  D L McGee,et al.  Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study , 1979, Diabetes Care.

[112]  D L McGee,et al.  Diabetes and Cardiovascular Risk Factors: The Framingham Study , 1979, Circulation.

[113]  W. Kannel,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[114]  M Marmot,et al.  Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. , 1977, The American journal of cardiology.

[115]  S. Syme,et al.  Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality. , 1975, American journal of epidemiology.

[116]  S. Syme,et al.  Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. , 1975, American journal of epidemiology.

[117]  A. Keys CORONARY HEART DISEASE IN SEVEN COUNTRIES , 1971, The Medical journal of Australia.

[118]  S. Bondurant Symposium on Research on Acute Myocardial Infarction , 1970 .

[119]  F. Epstein,et al.  EPIDEMIOLOGICAL STUDIES OF CARDIOVASCULAR DISEASE IN A TOTAL COMMUNITY--TECUMSEH, MICHIGAN. , 1965, Annals of internal medicine.

[120]  W. H. Phelan,et al.  A Longitudinal Study of Coronary Heart Disease , 1963, Circulation.

[121]  W. Kannel,et al.  Cigarette Smoking and Coronary Heart Disease , 1962 .

[122]  J. Stamler,et al.  Prevalence and incidence of coronary heart disease in strata of the labor force of a Chicago industrial corporation. , 1960, Journal of chronic diseases.